ARDX — Ardelyx Inc · rev $215.3M

Ardelyx Inc (ARDX) is a biotechnology company listed on US.

Latest reported ARDX revenue for 2026-06-30 was $215.3M. Net income was -$54.3M. ARDX currently screens at market cap $1.37B.

Use this ARDX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ARDX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ARDX SEC filings page. Lician reads the product cache first so this HTML stays unique to Ardelyx Inc even when a live quote feed is slow.

Ardelyx Inc latest statements (FY2025)

Latest cached year on this hub. Full ARDX income, balance, and cash tables.

  • Revenue$407.3M
  • Net Income-$61.6M
  • Total Assets$501.6M
  • Total Debt$0
  • Free Cash Flow-$44.0M

ARDX recent filings